Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1629614

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1629614

Lactated Ringers Injection Market, By Formulation, By Volume, By Age Group, By Container, By Distribution Channel, By Geography

PUBLISHED:
PAGES: 145 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

The global lactated ringers injection market is estimated to be valued at USD 510.1 Mn in 2024 and is expected to reach USD 762.2 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 510.1 Mn
Historical Data for: 2019 To 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 5.90% 2031 Value Projection: US$ 762.2 Mn
Figure. Lactated Ringers Injection Market Share (%), By Region 2024
Lactated Ringers Injection Market - IMG1

Lactated ringers injection is one of the most commonly prescribed intravenous fluids used for fluid resuscitation and management of dehydration. It helps restore electrolyte balance and fluid volume in the body. The global lactated ringers injection market has been witnessing steady growth in the recent past due to the rising prevalence of chronic diseases and injuries that require intravenous therapy. Furthermore, the growing geriatric population who are more prone to electrolyte imbalance is also contributing to the increased demand for lactated ringers injection. With growing awareness and improved access to healthcare facilities globally, the market is expected to continue its positive outlook over the forecast period.

Market Dynamics:

The global lactated ringers injection market has been experiencing steady growth attributed to the rising prevalence of chronic health conditions such as diabetes, cardiovascular diseases, and kidney ailments that often lead to electrolyte imbalance. Additionally, the growing risk of road accidents, injuries, and trauma cases requiring emergency fluid resuscitation are further propelling market growth. Furthermore, the growing geriatric population who are more susceptible to electrolyte disorders is creating high maintenance demand for lactated ringers injection. However, stringent regulations pertaining to intravenous fluid approvals may hinder market growth. Moreover, the availability of alternative IV therapy products acts as a restraint. On the other hand, increasing healthcare investments in emerging nations provide significant opportunities for market players.

Key Features of the Study:

This report provides in-depth analysis of the global lactated ringers injection market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global lactated ringers injection market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Baxter International Inc., B. Braun Melsungen AG, ICU Medical, Inc., Fresenius Kabi AG, Hospira, Inc., Otsuka Pharmaceutical Co., Ltd., Dechra Pharmaceuticals PLC, Vedco, Inc., Grifols S.A., Pfizer Inc., Amgen Inc., Eton Pharmaceuticals, Inc., Sagent Pharmaceuticals, Inc., and Aurobindo Pharma Limited

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global lactated ringers injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lactated ringers injection market

Market Segmentation

  • By Formulation Insights (Revenue, USD Mn, 2019 - 2031)
    • Standard Lactated Ringer's Solution
    • Lactated Ringer's with Additives (Dextrose, sodium chloride, etc.)
  • By Volume Insights (Revenue, USD Mn, 2019 - 2031)
    • 250 ml
    • 500 ml
    • 1,000 ml
  • By Age Group Insights (Revenue, USD Mn, 2019 - 2031)
    • Adults
    • Pediatrics
    • Geriatrics
  • By Container Insights (Revenue, USD Mn, 2019 - 2031)
    • Plastic Bottles
    • PVC Bags
    • Glass Bottles/Vials etc.
  • By Distribution Channel Insights (Revenue, USD Mn, 2019 - 2031)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Regional Insights (Revenue, USD Mn, 2019 - 2031)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Baxter International Inc.
    • Braun Melsungen AG
    • ICU Medical, Inc.
    • Fresenius Kabi AG
    • Hospira, Inc.
    • Otsuka Pharmaceutical Co., Ltd.
    • Dechra Pharmaceuticals PLC
    • Vedco, Inc.
    • Grifols S.A.
    • Pfizer Inc.
    • Amgen Inc.
    • Eton Pharmaceuticals, Inc.
    • Sagent Pharmaceuticals, Inc.
    • Aurobindo Pharma Limited
Product Code: CMI7567

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Lactated Ringers Injection Market, By Formulation
    • Global Lactated Ringers Injection Market, By Volume
    • Global Lactated Ringers Injection Market, By Age Group
    • Global Lactated Ringers Injection Market, By Container
    • Global Lactated Ringers Injection Market, By Distribution Channel
    • Global Lactated Ringers Injection Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Lactated Ringers Injection Market, By Formulation, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Standard Lactated Ringer's Solution
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Lactated Ringer's with Additives (Dextrose, sodium chloride, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

5. Global Lactated Ringers Injection Market, By Volume, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • 250 ml
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • 500 mL
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • 1,000 ml
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Lactated Ringers Injection Market, By Age Group, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Adults
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Pediatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Geriatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Lactated Ringers Injection Market, By Container, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Plastic Bottles
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • PVC Bags
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Glass Bottles/Vials etc.
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global Lactated Ringers Injection Market, By Distribution Channel, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

9. Global Lactated Ringers Injection Market, By Region, 2019 - 2031, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Formulation, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Volume, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Container, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Formulation, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Volume, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Container, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Formulation, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Volume, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Container, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Formulation, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Volume, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Container, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Formulation, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Volume, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Container, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Formulation, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Volume, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Container, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Baxter International Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Braun Melsungen AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • ICU Medical, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fresenius Kabi AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hospira, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Otsuka Pharmaceutical Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Dechra Pharmaceuticals PLC
  • Vedco, Inc.
  • Grifols S.A.
  • Pfizer Inc.
  • Amgen Inc.
  • Eton Pharmaceuticals, Inc.
  • Sagent Pharmaceuticals, Inc.
  • Aurobindo Pharma Limited

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!